Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Compound 15a was effective in inhibiting 5α-reductase.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

The research found that people's hair proteins vary, especially by ethnicity and body part, which could help identify individuals in forensic science.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

New anti-acne medications are being tested to offer alternatives to current treatments.

Gene differences may affect baldness treatment response in Korean men.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

A new compound shows promise as a topical treatment for hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

The compound 4c showed strong potential as an anticancer agent.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.